|
Market Closed -
OTC Markets
13:27:31 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | 0.00% |
|
0.00% | - |
| Market Cap | 6.06M 5.44M 5.03M 4.56M 8.51M 577M 8.61M 60.14M 23.95M 302M 22.75M 22.27M 959M | P/E 2021 |
-1.24x | P/E 2022 | -2.25x |
|---|---|---|---|---|---|
| Enterprise Value | 5.85M 5.25M 4.85M 4.39M 8.21M 557M 8.31M 58.01M 23.11M 292M 21.95M 21.49M 925M | EV / Sales 2021 |
-
| EV / Sales 2022 | - |
| Free-Float |
99.83% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0 |
| Current year | 0 | | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 0.01 |
| 5 years | 0 | | 0.14 |
| 10 years | 0 | | 0.97 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ajay Kala
CEO | Chief Executive Officer | - | 2023-01-19 |
Yana Popova
DFI | Director of Finance/CFO | 44 | 2017-11-14 |
Bob Mehr
PRN | Corporate Officer/Principal | - | 2022-04-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Sean Bromley
BRD | Director/Board Member | 36 | 2019-12-18 |
Yana Popova
BRD | Director/Board Member | 44 | 2017-11-14 |
George Vrabec
BRD | Director/Board Member | - | 2022-04-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/24/23 | Other | 0 | 0% | - | ||
| 1/24/23 | Other | 0 | 0% | - | ||
| 1/24/23 | Other | 0 | 0% | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | 176 | |
| +0.50% | +1.38% | +57.09% | +127.73% | 1,143B | |
| +0.86% | +5.14% | +45.00% | +84.34% | 647B | |
| -0.14% | +0.42% | +25.69% | +101.56% | 506B | |
| -0.05% | +2.28% | +49.14% | +67.74% | 384B | |
| -0.63% | -5.97% | +61.93% | +37.25% | 350B | |
| +0.34% | +2.15% | +25.26% | +54.27% | 293B | |
| -0.45% | +1.16% | +1.74% | +26.08% | 265B | |
| +0.87% | +3.08% | +54.69% | +71.67% | 242B | |
| +0.08% | +3.67% | +35.05% | +104.71% | 197B | |
| Average | +0.47% | +0.76% | +39.51% | +75.04% | 402.75B | |
| Weighted average by Cap. | +0.79% | +0.71% | +43.68% | +87.36% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | - | - |
| Net income | -25.16M -22.57M -20.87M -18.9M -35.31M -2.4B -35.73M -249M -99.37M -1.25B -94.4M -92.41M -3.98B | -4.69M -4.21M -3.89M -3.53M -6.59M -447M -6.67M -46.54M -18.54M -234M -17.61M -17.24M -743M |
| Net Debt | -1.96M -1.76M -1.62M -1.47M -2.75M -187M -2.78M -19.42M -7.74M -97.6M -7.35M -7.19M -310M | -214K -192K -177K -161K -300K -20.38M -304K -2.12M -845K -10.66M -803K -786K -33.85M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-28 | US$0.000001 | 0.00% | 35,549 |
| 26-10-26 | US$0.000001 | 0.00% | 2,000 |
- Stock Market
- Stocks
- ISCNF Stock
Select your edition
All financial news and data tailored to specific country editions
